Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and babies; and its Pediatrics products treat allergies, asthma, and attention deficit/hyperactivity disorder. Founded in 1992, Sciele Pharma employs more than 1,000 people. In October 2008, Shionogi & Co., Ltd. acquired Sciele, which now operates as an indirect wholly owned subsidiary of Shionogi.
Name changed to Shionogi Pharma, Inc. on January 12, 2010.